皇城网上注册 - 【欢迎您!】

皇城网上注册



      DISCOVER皇城网上注册

      VASCEPA®

      EXPERIENCED皇城网上注册

      in lipid science

      INVESTOR皇城网上注册

      relations

      VASCEPA®皇城网上注册

      皇城网上注册

      皇城网上注册

      皇城网上注册


      therapeutics to improve cardiovascular health

      Amarin Corporation plc is a rapidly growing, innovative pharmaceutical company focused on developing and commercializing therapeutics to cost-effectively improve cardiovascular health. Amarin’s lead product, VASCEPA® (icosapent ethyl) capsules, is available by prescription in the United States and an increasing number of other countries.

      The History of VASCEPA®皇城网上注册


      Development of VASCEPA® leveraged Amarin’s extensive experience in the therapeutic benefits of polyunsaturated fatty acids and lipid science. The development of VASCEPA® challenged previously established understandings of the treatment of complex disease states and created an important new drug with the potential to significantly improve patient care for millions of patients. The use of VASCEPA® is supported by over 200 issued patents worldwide. VASCEPA® was designated by FDA as a new chemical entity in recognition of the drug’s novel single active ingredient. Similar designations have also been granted to VASCEPA®’s active ingredient in other jurisdictions internationally.

      MORE

      皇城网上注册


      皇城网上注册

      VASCEPA® (icosapent ethyl) Data from REDUCE-IT® REVASC, Including New Data on Timeframe to Demonstrated Benefit, Presented as Encore at The American Society for Preventive Cardiology 2020 Virtual Summit on CVD (Cardiovascular Disease) Prevention MORE

      皇城网上注册

      Amarin to Report Second Quarter 2020 Results and Host Conference Call on August 4, 2020 MORE

      皇城网上注册

      Symbol:
      AMRN (NASDAQ)
      Quote:
      $6.59
      Change:
      +0.14
      Date:
      4:00 PM on Jul 30, 2020
      (latest end of day stock price)

      皇城网上注册

      ALL PRESS RELEASES
      STOCK INFO
      Investor
      皇城网上注册:优游游戏网址 亲爱的来吃饭歌舞青春卡司重聚金妍儿:帝一真人娱乐
      Executive
      皇城网上注册:疯狂7体育备用 魔道祖师下一位前度魏大勋:帝一真人娱乐
      Career
      皇城网上注册:众发娱乐登入 阿根廷5.4级地震新冠病毒长期存在寻情记:帝一真人娱乐
      皇城网上注册:永利外围足球 途牛否认破产清算无心法师3东莞日报:帝一真人娱乐
      Contact
      皇城网上注册:博中乐国际在线 罗志祥妈妈发声58同城私有化赵丽颖:帝一真人娱乐

      Amarin
      Corporation皇城网上注册

      therapeutics to improve
      cardiovascular health.

      皇城网上注册

      You may automatically receive Amarin Corporation plc financial information by email.


      Click To Subscribe

      
          帝一真人娱乐32棋牌手机下载凯发ag旗舰32棋牌手机下载奔驰宝马篮球投注奔驰宝马篮球投注32凯发ag旗舰凯发ag旗舰32棋牌手机下载
          baiduxml